🚀 VC round data is live in beta, check it out!
Lepu Medical Technology Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lepu Medical Technology and similar public comparables like Ottobock, Envista Holdings, Novanta, Merit Medical Systems and more.
Lepu Medical Technology Overview
About Lepu Medical Technology
Lepu Medical Technology (Beijing) Co Ltd is a China-based company. It specializes in developing, manufacturing, and marketing high-tech medical devices and equipment. The company is engaged in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia, and critical care, in vitro diagnostics and general surgery.
Founded
2008
HQ
Employees
510
Website
Financials (LTM)
EV
$5B
Lepu Medical Technology Financials
Lepu Medical Technology reported last 12-month revenue of $1B and EBITDA of $298M.
In the same LTM period, Lepu Medical Technology generated $646M in gross profit, $298M in EBITDA, and $172M in net income.
Revenue (LTM)
Lepu Medical Technology P&L
In the most recent fiscal year, Lepu Medical Technology reported revenue of $895M and EBITDA of $145M.
Lepu Medical Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $895M | XXX | XXX | XXX |
| Gross Profit | $646M | XXX | $545M | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $298M | XXX | $145M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $172M | XXX | $36M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | — | — | $31M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lepu Medical Technology Stock Performance
Lepu Medical Technology has current market cap of $4B, and enterprise value of $5B.
Market Cap Evolution
Lepu Medical Technology's stock price is $2.40.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $4B | 0.0% | XXX | XXX | XXX | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLepu Medical Technology Valuation Multiples
Lepu Medical Technology trades at 4.6x EV/Revenue multiple, and 15.8x EV/EBITDA.
EV / Revenue (LTM)
Lepu Medical Technology Financial Valuation Multiples
As of April 20, 2026, Lepu Medical Technology has market cap of $4B and EV of $5B.
Equity research analysts estimate Lepu Medical Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lepu Medical Technology has a P/E ratio of 25.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | 15.8x | XXX | 32.4x | XXX | XXX | XXX |
| EV/EBIT | 23.0x | XXX | 44.7x | XXX | XXX | XXX |
| EV/Gross Profit | 7.3x | XXX | 8.6x | XXX | XXX | XXX |
| P/E | 25.7x | XXX | 122.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 422.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lepu Medical Technology Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lepu Medical Technology Margins & Growth Rates
Lepu Medical Technology's revenue in the last 12 month grew by 15%.
Lepu Medical Technology's revenue per employee in the last FY averaged $1.8M, while opex per employee averaged $0.9M for the same period.
Lepu Medical Technology's rule of 40 is 44% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lepu Medical Technology's rule of X is 66% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Lepu Medical Technology Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 98% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 44% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 17% | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 22% | XXX | 12% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lepu Medical Technology Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lepu Medical Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| Ottobock | XXX | XXX | XXX | XXX | XXX | XXX |
| Envista Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Novanta | XXX | XXX | XXX | XXX | XXX | XXX |
| Merit Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Medacta Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lepu Medical Technology M&A Activity
Lepu Medical Technology acquired XXX companies to date.
Last acquisition by Lepu Medical Technology was on XXXXXXXX, XXXXX. Lepu Medical Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lepu Medical Technology
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLepu Medical Technology Investment Activity
Lepu Medical Technology invested in XXX companies to date.
Lepu Medical Technology made its latest investment on XXXXXXXX, XXXXX. Lepu Medical Technology invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lepu Medical Technology
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lepu Medical Technology
| When was Lepu Medical Technology founded? | Lepu Medical Technology was founded in 2008. |
| Where is Lepu Medical Technology headquartered? | Lepu Medical Technology is headquartered in China. |
| How many employees does Lepu Medical Technology have? | As of today, Lepu Medical Technology has over 510 employees. |
| Is Lepu Medical Technology publicly listed? | Yes, Lepu Medical Technology is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Lepu Medical Technology? | Lepu Medical Technology trades under 300003 ticker. |
| When did Lepu Medical Technology go public? | Lepu Medical Technology went public in 2009. |
| Who are competitors of Lepu Medical Technology? | Lepu Medical Technology main competitors are Ottobock, Envista Holdings, Novanta, Merit Medical Systems. |
| What is the current market cap of Lepu Medical Technology? | Lepu Medical Technology's current market cap is $4B. |
| What is the current revenue of Lepu Medical Technology? | Lepu Medical Technology's last 12 months revenue is $1B. |
| What is the current revenue growth of Lepu Medical Technology? | Lepu Medical Technology revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Lepu Medical Technology? | Current revenue multiple of Lepu Medical Technology is 4.6x. |
| Is Lepu Medical Technology profitable? | Yes, Lepu Medical Technology is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Lepu Medical Technology? | Lepu Medical Technology's last 12 months EBITDA is $298M. |
| What is Lepu Medical Technology's EBITDA margin? | Lepu Medical Technology's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Lepu Medical Technology? | Current EBITDA multiple of Lepu Medical Technology is 15.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.